Thomas J. Lamb – Law Offices of Thomas J. Lamb, P.A.

Pneumonia Trial Of Janssen / J&J Antibiotic Doribax Was Stopped In May 2011 -- We Learn From The FDA In January 2012 Significant Safety Concern": Higher Death Rate For Doribax In Ventilator-Associated Pneumonia When Compared…more

YAZ / Yasmin January 2012 Update: Minutes And Transcripts For FDA Advisory Committees 2011 Meeting Now Available Online (And More) 11 Of The 26 FDA Panel Members Voted There Were No Sufficient Unique Benefits For YAZ / Yasmin…more

Safety Profile Of New Stroke Drug Has Been Tarnished By Various Adverse Event Reports FDA Reviewing Serious Side Effects Associated With Pradaxa Ranging From Heart Attacks To Serious Bleeding or…more

Prescription Drug Medication Errors Can Be Prevented By Taking Some Common Sense Precautions Ten Strategies Intended For Pharmacists Can Help Patients Stay Safe,…more

Fosamax Osteonecrosis Of The Jaw (ONJ) Federal Court MDL Litigation: A Mixed Forecast For 2012 Three More Lawsuits (Boles, Jellema, and Spano) Set For Trial, And A Special Master Appointed To Conduct Settlement…more

Women Who Use Bisphosphonates Like Fosamax And Boniva Have Increased Risk Of Femur Fracture / Thigh Bone Breaks December 2011: Some Recent Medical Studies About These Bisphosphonate-Related Subtorchanteric Or Atypical Femoral…more

Pradaxa: FDA Investigating Possible Higher Than Expected Incident Rate Of Serious Bleeding Side Effects Adverse Event Reports For This New Blood Thinner Drug May Exceed Pre-Approval Clinical Trial…more

Ortho Evra: December 2011 FDA Advisory Committees Meeting Background Materials Now Available Online J&J Birth Control Patch Ortho Evra Safety Review Will Focus On Blood Clot Side Effects Like Pulmonary Embolism (PE) And Deep…more

YAZ / Yasmin: December 2011 FDA Advisory Committees Meeting Background Materials Now Available Online Expert Reports From YAZ / Yasmin Lawsuits Will Not Be Considered Because Submitted After Deadline Set By…more

Another Generic YAZ Birth Control Pill Is Approved, Just One Week Before FDA Drug Safety Meeting Coincidence, But Ironic, Given Several Recent Medical Studies Which Suggest Drospirenone (DRSP) Causes Blood…more

Sanofi Heart Drug Multaq Found To Be Dangerous For Patients With Permanent Atrial Fibrillation Analysis Of PALLAS Study Data Shows Two-Times Increased Risk Of Death, Stroke, And Heart…more

Byetta And Januvia: More Debate About The Possible Increased Risk Of Pancreatitis, Pancreatic Cancer, And Thyroid Cancer Level Of Concern About These Incretin Therapies For Diabetes Was Raised By Gastroenterology Medical…more

Two More Medical Studies Show Increased Risk Of Blood Clots With Use Of YAZ, Yasmin, And Ocella Researchers Find Drospirenone (DRSP) Containing Birth Control Pills Increased Risk Of Pulmonary Embolism (PE) And Deep Vein…more

Ortho Evra Update: October 2011 FDA Study Finds Increased Risk Of Blood Clot Side Effects Deep Vein Thrombosis & Pulmonary Embolism Given These New FDA Drug Safety Findings About Ortho Evra, What Will Two Advisory Committees…more

YAZ / Yasmin / Ocella Update: October 2011 FDA Study Finds Increased Risk Of Blood Clot Side Effects Like DVT, PE, Stroke, And Heart Attack Safety Study Findings About Drospirenone (DRSP) Birth Control Pills Will Be On The…more